Subcutaneous efgartigmod with recombinant human hyaluronidase PH20 for treating primary immune thrombocytopenia [TSID11977]

  • Awaiting development
  • GID-TA11507
  • Expected publication date: TBC

NIHRIO BN: 30972-Efgartigimod-PH20-SC-for-Immune-Thrombocytopenia-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)